Nkarta NKTX
NASDAQ NKTX
$1.78 +0.03 (+2.00%)
As of: Oct 22, 2026 · 11:54 AM EDT

Nkarta (NKTX) Other financing activities (2020 - 2021)

Updated

Analysis

Nkarta (NKTX) Other financing activities (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn
10 Nkarta 132.97 Mn -1.55 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -147,000.00
Jun 30, 2020 -1.73 Mn
Mar 31, 2020 -711,000.00
API Access

Nkarta Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=NKTX&period=max&api_key=YOUR_API_KEY